Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Merck
UBS
Julphar
Cipla
US Army
Dow
Boehringer Ingelheim
US Department of Justice
Accenture

Generated: January 17, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Patritumab

« Back to Dashboard

US Patents for Patritumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Patritumab ➤ Try a Free Trial Multispecific constructs AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Try a Free Trial
Patritumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Patritumab ➤ Try a Free Trial P97 fragments with transfer activity biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Try a Free Trial
Patritumab ➤ Try a Free Trial Fragments of p97 and uses thereof biOasis Technologies, Inc. (Richmond, CA) ➤ Try a Free Trial
Patritumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Patritumab ➤ Try a Free Trial Anti-CD324 monoclonal antibodies and uses thereof ABBVIE STEMCENTRX LLC (North Chicago, IL) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Patritumab

Drugname Country Document Number Estimated Expiration Related US Patent
Patritumab Canada 2900764 2033-02-08 ➤ Try a Free Trial
Patritumab European Patent Office 2954056 2033-02-08 ➤ Try a Free Trial
Patritumab Hong Kong 1218930 2033-02-08 ➤ Try a Free Trial
Patritumab Japan 2016509014 2033-02-08 ➤ Try a Free Trial
Patritumab World Intellectual Property Organization (WIPO) 2014124326 2033-02-08 ➤ Try a Free Trial
Patritumab Australia 2012294673 2031-08-05 ➤ Try a Free Trial
Patritumab Canada 2842492 2031-08-05 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Medtronic
Cantor Fitzgerald
Cipla
Accenture
Fuji
US Army
Argus Health
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.